Merck's joint venture with the Wellcome trust to develop vaccines for the developing and less-developed world is a potentially pathbreaking solution to address the needs of these constituencies. But apart from the vaccines that this joint venture will hopefully help bring to market at affordable prices, it also has other benefits. One, the JV is … Continue reading Merck-Wellcome trust JV spillovers
Apothecurry 